Sales growth driven by continued strong performance from priority brands including Kisqali (+57% cc), Kesimpta (+36% cc), Pluvicto (+42% cc), Scemblix (+85% cc) and Cosentyx (+8% cc) Operating income ...
Ad hoc announcement pursuant to Art. 53 LR Full year Net sales grew +8% (cc1, +8% USD) with core operating income1 up +14% (cc, +12% USD) Sales growth driven by continued strong performance ...
CTSH heads into Q4 earnings with rising earnings expectations, solid revenue growth forecasts and momentum from large deals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results